SCHEMBL4284988

SCHEMBL4284988

CCOC(=O)COC1CCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
POLB P06746 3/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 7/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
ALDH1A1 P00352 7/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MEN1 O00255 2/20 0.35
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 4/20 0.35
TSHR P16473 3/20 0.35
NLRP3 Q96P20 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374442 0.95 KMT2A (0.44) KMT2APOLBLMNAHPGDCYP1A2
SCHEMBL20837278 0.83 MGAM (0.39) KMT2AHPGDCYP1A2CYP2C9CYP2C19
SCHEMBL21469084 0.83 KMT2A (0.44) KMT2AHPGDRAB9ANPC1ALDH1A1
SCHEMBL20548080 0.81 KMT2A (0.41) KMT2AHPGDCYP1A2RAB9ANPC1
SCHEMBL22071027 0.81 KMT2A (0.49) KMT2APOLBLMNAMEN1
SCHEMBL11076267 0.80 MEN1 (0.48) KMT2APOLBLMNARAB9AALDH1A1
SCHEMBL25176578 0.80 KMT2A (0.44) KMT2APOLBLMNACYP1A2RAB9A
SCHEMBL21068614 0.79 KMT2A (0.47) KMT2AMEN1
SCHEMBL8568806 0.79 MGAM (0.48) KMT2APOLBLMNAHPGDCYP1A2
SCHEMBL8569091 0.79 MGAM (0.48) KMT2APOLBLMNAHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 KMT2A 1397/4885POLB 4872/4885LMNA 3975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.